Business Effectiveness Cited As Key Component Of Compliance Programs
This article was originally published in The Gray Sheet
Executive Summary
Business considerations are as important as legal requirements for effective compliance programs, TAP Pharmaceutical Products VP and Ethics & Compliance Officer Stephan Vincze said Sept. 14 at a Food & Drug Law Institute meeting in Washington, D.C